Trademark: 97978251
Word
INGREZZA
Status
Pending
Status Code
819
Status Date
Thursday, September 12, 2024
Serial Number
97978251
Mark Type
3
Filing Date
Friday, November 11, 2022
Published for Opposition
Tuesday, October 10, 2023

Trademark Owner History
Neurocrine Biosciences, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for movement disorders, namely, chorea associated with Huntington's Disease
The mark consists of a sequence of right pointing arrows and the word "INGREZZA".
Color is not claimed as a feature of the mark.

Trademark Events
Dec 3, 2022
New Application Office Supplied Data Entered
Nov 15, 2022
New Application Entered
Dec 6, 2022
Notice Of Design Search Code E-Mailed
Apr 19, 2023
Teas Change Of Correspondence Received
Aug 25, 2023
Assigned To Examiner
Oct 10, 2023
Published For Opposition
Apr 19, 2023
Teas Change Of Owner Address Received
Apr 19, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 19, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 20, 2023
Notification Of Notice Of Publication E-Mailed
Apr 19, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 5, 2023
Approved For Pub - Principal Register
Oct 10, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2024
Teas Request To Divide Received
Apr 12, 2024
Teas Statement Of Use Received
Apr 12, 2024
Divisional Request Received
Apr 12, 2024
Use Amendment Filed
Apr 23, 2024
Case Assigned To Intent To Use Paralegal
Dec 5, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 11, 2024
Teas Change Of Correspondence Received
Jul 11, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 11, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 10, 2024
Statement Of Use Processing Complete
Sep 10, 2024
Divisional Processing Complete
Sep 12, 2024
Allowed Principal Register - Sou Accepted
Sep 12, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24